TESATROPE

Roger Pharma TESATROPE (Tesamorelin) is a peptide formulation containing Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate endogenous growth hormone secretion. It is commonly researched for its potential role in body composition, metabolic regulation, growth hormone pathways, and endocrine function. Each pack contains 5 vials, with 6 mg of Tesamorelin per vial, providing a total peptide content of 30 mg. Roger Pharma TESATROPE is supplied in a lyophilized format and is intended for research applications involving peptide science, endocrinology, metabolism, and growth hormone studies. Key Features Tesamorelin peptide formulation 6 mg per vial 5 vials per pack Total peptide content: 30 mg Lyophilized peptide format Studied for growth hormone-releasing hormone pathways Research-focused peptide compound Contents Active Ingredient: Tesamorelin – 6 mg Quantity: 5 Vials